文献速递角膜与眼表疾病

微孢子虫性角膜基质炎:临床特征、电镜超微结构及不同手术方式疗效

Microsporidial stromal keratitis: characterisation of clinical features, ultrastructural study by electron microscopy and efficacy of different surgical modalities.
PubMed 文献 · Br J Ophthalmol · 2020-02-12

所有患者对药物治疗无效,最终接受板层角膜切除或穿透性角膜移植,术后感染清除率78.6%,但3年内复发率21.4%,仅2例最终视力≥20/100。

要点

  • 角膜刮片Gram染色阳性12例(85.7%),改良Ziehl-Neelsen染色阳性9例(64.3%)。
  • 小亚基rRNA PCR测序在82%患者中鉴定出Vittaforma corneae。
  • 所有患者药物治疗无效后手术,术后感染清除率78.6%,3年复发率21.4%。

核心结论

  • 微孢子虫性角膜基质炎常表现为非特异性角膜浸润且对抗微生物治疗无效,诊断依赖角膜刮片光镜检查和病理分析。
  • 手术干预可限制感染,但总体预后差,复发率较高且最终视力较差。

研究设计与样本

  • 每例患者均回顾临床表现、光镜、组织病理学、PCR及角膜样本电镜检查。

主要发现

  • 患者年龄70.0±4.7岁,平均随访4.5年,症状出现至就诊时间10.6±13.0周。
  • 角膜表现高度可变,角膜刮片Gram染色阳性12例(85.7%),改良Ziehl-Neelsen染色阳性9例(64.3%)。
  • 组织病理学所有标本均见孢子,小亚基rRNA PCR产物测序在82%患者中鉴定出Vittaforma corneae。
  • 电镜显示角膜细胞内有多种形态的微孢子虫孢子质。
  • 所有患者均接受局部抗微生物药物或联合口服抗寄生虫药治疗>3周,均对药物治疗无效。

关键数值与推荐

  • 所有患者最终接受手术:7例治疗性板层角膜切除(TLK),6例穿透性角膜移植(PK),1例先行TLK后行PK。
  • 术后感染清除率78.6%,3年随访期间复发率21.4%。
  • 仅2例患者最终视力保持≥20/100。

临床怎么用

  • 对非特异性角膜基质浸润且抗微生物治疗无效者,应考虑微孢子虫性角膜基质炎,行角膜刮片光镜和病理检查。
  • 药物治疗无效时可行手术治疗,但需告知患者预后较差且复发风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To report the clinical manifestations, ultrastructure and evaluate the efficacy of therapeutic lamellar keratectomy (TLK) and penetrating keratoplasty (PK) for microsporidial stromal keratitis (MSK). METHODS: Fourteen MSK cases between 2009 and 2018 were recruited. Each patient's clinical presentation, light microscopy, histopathology, PCR and electron microscopy (EM) of corneal samples were reviewed. RESULTS: The patients were 70.0±4.7 years old (average follow-up, 4.5 years). Time from symptoms to presentation was 10.6±13.0 weeks. The corneal manifestations were highly variable. Corneal scrapings revealed Gram stain positivity in 12 cases (85.7%) and modified Ziehl-Neelsen stain positivity in 9 (64.3%). Histopathology revealed spores in all specimens, while sequencing of small subunit rRNA-based PCR products identified Vittaforma corneae in 82% of patients. EM demonstrated various forms of microsporidial sporoplasm in corneal keratocytes. All patients were treated with topical antimicrobial agents or combined with oral antiparasitic medications for >3 weeks. As all patients were refractory to medical therapy, they ultimately underwent surgical intervention (TLK in 7, PK in 6 and 1 received TLK first, followed by PK). Postoperatively, the infection was resolved in 78.6% of the patients. Nevertheless, a high recurrence rate (21.4%) was noted during 3-year follow-up, with only two patients retained a final visual acuity ≥20/100. CONCLUSION: MSK usually presents with a non-specific corneal infiltration refractory to antimicrobial therapy. The diagnosis relies on light microscopic examinations on corneal scrapings and histopathological analyses. Surgical intervention is warranted by limiting the infection; however, it was associated with an overall poor outcome.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Huang HY, Wu CL, Lin SH, et al. Microsporidial stromal keratitis: characterisation of clinical features, ultrastructural study by electron microscopy and efficacy of different surgical modalities. Br J Ophthalmol. 2020. PMID: 32051138. doi:10.1136/bjophthalmol-2019-315094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。